These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis]. Author: Kullmann T, Gauthier H, le Maignan C, Szabó A, Culine S. Journal: Orv Hetil; 2012 Sep 02; 153(35):1385-8. PubMed ID: 22935431. Abstract: Lung and breast cancer can give meningeal metastases. Clinical manifestations of leptomeningeal carcinomatosis include all forms of defect of the central nervous system depending on the localization of carcinomatous foci. Diagnosis is based on the detection of carcinomatous cells by the cytological examination of the cerebrospinal fluid. Without treatment the prognosis is limited to only some weeks or months. In case the meningeal carcinomatosis is related to breast cancer, intrathecal methotrexate chemotherapy may allow a significant survival benefit and improve the quality of life in about half of the patients.[Abstract] [Full Text] [Related] [New Search]